Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Vertex Pharmaceuticals Wowed With Its Q2 Results

TheMotleyFool

0 0

How Vertex Pharmaceuticals Wowed With Its Q2 ResultsPhoto, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Vertex Pharmaceuticals (NASDAQ: VRTX) has been on a roll so far in 2020. The big biotech delivered strong growth in the first quarter. It received a positive opinion from the European Medical Agency's Committee for Medicinal Products for Human Use regarding the potential approval of cystic fibrosis (CF) drug Kaftrio. And its shares have soared nearly 29% year to date.

The company announced its second-quarter results after the market closed on Thursday. It looks like Vertex's good times will keep rolling. Here are the highlights from the biotech's Q2 update.

Image Source: Getty Images.

Source Fool.com

Like: 0

VRTX

Share